Related references
Note: Only part of the references are listed.Increasing Ancestral Diversity in Systemic Lupus Erythematosus Clinical Studies
Jessica N. Williams et al.
ARTHRITIS CARE & RESEARCH (2022)
Anti-RNP antibodies are associated with the interferon gene signature but not decreased complement levels in SLE
Erika L. Hubbard et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Gene signature fingerprints stratify SLE patients in groups with similar biological disease profiles: a multicentre longitudinal study
M. Javad Wahadat et al.
RHEUMATOLOGY (2022)
Modular gene analysis reveals distinct molecular signatures for subsets of patients with cutaneous lupus erythematosus
J. L. Zhu et al.
BRITISH JOURNAL OF DERMATOLOGY (2021)
Global epidemiology of systemic lupus erythematosus
Megan R. W. Barber et al.
NATURE REVIEWS RHEUMATOLOGY (2021)
Population-based RNA profiling in Add Health finds social disparities in inflammatory and antiviral gene regulation to emerge by young adulthood
Steven W. Cole et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus
Michelle D. Catalina et al.
JCI INSIGHT (2020)
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Antonis Fanouriakis et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Epigenome-wide association study of peripheral blood mononuclear cells in systemic lupus erythematosus: Identifying DNA methylation signatures associated with interferon-related genes based on ethnicity and SLEDAI
Stancy Joseph et al.
JOURNAL OF AUTOIMMUNITY (2019)
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary
Caroline Gordon et al.
RHEUMATOLOGY (2018)
Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register
Eoghan M. McCarthy et al.
RHEUMATOLOGY (2018)
Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status
Md Yuzaiful Md Yusof et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
The genetics and molecular pathogenesis of systemic lupus erythematosus (SLE) in populations of different ancestry
George N. Goulielmos et al.
GENE (2018)
Genetic contributions to lupus nephritis in a multi-ethnic cohort of systemic lupus erythematous patients
Cristina M. Lanata et al.
PLOS ONE (2018)
A novel two-score system for interferon status segregates autoimmune diseases and correlates with clinical features
Y. M. El-Sherbiny et al.
SCIENTIFIC REPORTS (2018)
The plasma biomarker soluble SIGLEC-1 is associated with the type I interferon transcriptional signature, ethnic background and renal disease in systemic lupus erythematosus
Joao J. Oliveira et al.
ARTHRITIS RESEARCH & THERAPY (2018)
Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort
Sarah L. Tansley et al.
JOURNAL OF AUTOIMMUNITY (2017)
Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus
Medha Barbhaiya et al.
ARTHRITIS & RHEUMATOLOGY (2017)
46-Year Trends in Systemic Lupus Erythematosus Mortality in the United States, 1968 to 2013 A Nationwide Population-Based Study
Eric Y. Yen et al.
ANNALS OF INTERNAL MEDICINE (2017)
Predicting and managing primary and secondary non-response to rituximab using B-cell biomarkers in systemic lupus erythematosus
Md Yuzaiful Md Yusof et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients
Romain Banchereau et al.
CELL (2016)
Network Analysis Identifies Proinflammatory Plasma Cell Polarization for Secretion of ISG15 in Human Autoimmunity
Matthew A. Care et al.
JOURNAL OF IMMUNOLOGY (2016)
New insights into the immunopathogenesis of systemic lupus erythematosus
George C. Tsokos et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry
Laura Plantinga et al.
ARTHRITIS CARE & RESEARCH (2016)
RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities
Richa Rai et al.
PLOS ONE (2016)
Factors associated with damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) Inception Cohort
Ian N. Bruce et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Birmingham SLE cohort: outcomes of a large inception cohort followed for up to 21 years
Chee-Seng Yee et al.
RHEUMATOLOGY (2015)
On non-detects in qPCR data
Matthew N. McCall et al.
BIOINFORMATICS (2014)
UpSet: Visualization of Intersecting Sets
Alexander Lex et al.
IEEE TRANSACTIONS ON VISUALIZATION AND COMPUTER GRAPHICS (2014)
Modular Transcriptional Repertoire Analyses of Adults With Systemic Lupus Erythematosus Reveal Distinct Type I and Type II Interferon Signatures
Laurent Chiche et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Elevated Serum BAFF Levels Are Associated With Rising Anti-Double-Stranded DNA Antibody Levels and Disease Flare Following B Cell Depletion Therapy in Systemic Lupus Erythematosus
Lucy M. Carter et al.
ARTHRITIS AND RHEUMATISM (2013)
PTPN22 Association in Systemic Lupus Erythematosus (SLE) with Respect to Individual Ancestry and Clinical Sub-Phenotypes
Bahram Namjou et al.
PLOS ONE (2013)
Activation of the interferon patnway is dependent upon autoantibodies in African-American SLE patients, but not in European-American SLE patients
Kichul Ko et al.
FRONTIERS IN IMMUNOLOGY (2013)
IRF5 haplotypes demonstrate diverse serological associations which predict serum interferon alpha activity and explain the majority of the genetic association with systemic lupus erythematosus
Timothy B. Niewold et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
B Cell Biomarkers of Rituximab Responses in Systemic Lupus Erythematosus
Edward M. Vital et al.
ARTHRITIS AND RHEUMATISM (2011)
Network Analysis of Associations Between Serum Interferon-α Activity, Autoantibodies, and Clinical Features in Systemic Lupus Erythematosus
Corinna E. Weckerle et al.
ARTHRITIS AND RHEUMATISM (2011)
B lymphocyte stimulator levels in systemic lupus erythematosus: Higher circulating levels in African American patients and increased production after influenza vaccination in patients with low baseline levels
Lauren L. Ritterhouse et al.
ARTHRITIS AND RHEUMATISM (2011)
Efficacy and Safety of Rituximab in Moderately-to-Severely Active Systemic Lupus Erythematosus The Randomized, Double-Blind, Phase II/III Systemic Lupus Erythematosus Evaluation of Rituximab Trial
Joan T. Merrill et al.
ARTHRITIS AND RHEUMATISM (2010)
Numerical scoring for the BILAG-2004 index
Chee-Seng Yee et al.
RHEUMATOLOGY (2010)
B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response
G. Cambridge et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Anti-synthetase syndrome: a new autoantibody to phenylalanyl transfer RNA synthetase (anti-Zo) associated with polymyositis and interstitial pneumonia
Z. Betteridge et al.
RHEUMATOLOGY (2007)
BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus
DA Isenberg et al.
RHEUMATOLOGY (2005)
Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6
G Jego et al.
IMMUNITY (2003)
Share Paper
